Polymorphism | Genotype | Patient | Control | OR | 95% CI |
---|
Arg16Gly (c.46A > G)
1,2
| Homozygous Arg16 | 28 | 9 |
6.782
|
3.07-16.03
|
Heterozygous | 38 | 59 | 1.056 | 0.61-1.81 |
Homozygous Gly16 | 22 | 73 |
0.312
|
0.17-0.56
|
|
Total
|
88
|
141
| | |
Gln27Glu(c.79C > G)
3,4
| Homozygous Gln27 | 41 | 41 |
2.120
|
1.22-3.71
|
Heterozygous | 36 | 11 |
8.096
|
3.90-17.77
|
Homozygous Glu27 | 11 | 89 |
0.084
|
0.04-0.17
|
|
Total
|
88
|
141
| | |
- ADR2 = alpha2-adrenergic receptor; Arg = arginine; Gly = Glycine; Gln = Glutamine; Glu = Glutamic acid; A = Adenine; G = Guanine; T = Thymine; OR = Odds Ratio; CI = Confidence Interval.
- Hardy-Weinberg equilibrium was calculated using the OEGE tool (http://www.oege.org/software/hardy-weinberg.html), being: (1 - patient) χ2 = 1.54, p-value > 0.05; (2 - control) χ2 = 0.48, p-value > 0.05; (3 - patient) χ2 = 0.41, p-value > 0.05; (4 - control) χ2 = 95.62, p-value < 0.001.
- The OR was calculated using the Open-Epi tool (http://www.openepi.com). The OR and 95% CI values were obtained using the Mild-P test. For all data analyzed, α = 0.05 was used. The significant p-values are in bold.